FISH Monosomy 7 del7q31 for AML MDS Test
Comprehensive Genetic Analysis for Blood Cancer Diagnosis
The FISH Monosomy 7 del7q31 test represents a cutting-edge diagnostic approach in the field of hematological malignancies. This specialized cytogenetic analysis utilizes Fluorescence In Situ Hybridization (FISH) technology to detect critical chromosomal abnormalities that play a pivotal role in the development and progression of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS). By identifying specific genetic alterations on chromosome 7, this test provides invaluable insights for accurate diagnosis, prognosis assessment, and treatment planning.
What This Advanced Test Detects
The FISH Monosomy 7 del7q31 test specifically targets and identifies:
- Monosomy 7: Complete loss of one copy of chromosome 7
- del7q31 deletion: Specific deletion within the 7q31 chromosomal region
- Chromosomal abnormalities associated with poor prognosis in AML and MDS
- Genetic markers that influence treatment response and disease progression
Who Should Consider This Genetic Test?
This specialized genetic analysis is recommended for individuals experiencing:
- Unexplained cytopenias (low blood cell counts)
- Abnormal blood cell morphology detected in peripheral blood smears
- Suspected or confirmed diagnosis of Myelodysplastic Syndromes
- Newly diagnosed Acute Myeloid Leukemia requiring comprehensive genetic profiling
- Patients with high-risk MDS features requiring prognostic assessment
- Individuals with family history of hematological malignancies
- Patients undergoing treatment monitoring for AML or MDS
Significant Benefits of Genetic Testing
Undergoing the FISH Monosomy 7 del7q31 test provides multiple clinical advantages:
- Accurate Prognostic Assessment: Identifies high-risk genetic features that influence disease outcomes
- Personalized Treatment Planning: Guides selection of appropriate therapeutic strategies
- Early Detection Capabilities: Enables timely intervention for better patient outcomes
- Comprehensive Risk Stratification: Helps categorize patients into appropriate risk groups
- Treatment Response Monitoring: Assists in evaluating effectiveness of ongoing therapies
- Family Risk Assessment: Provides insights into potential hereditary factors
Understanding Your Test Results
Your FISH Monosomy 7 del7q31 test results will be carefully interpreted by our expert cytogeneticists:
- Normal Results: No detected abnormalities on chromosome 7, suggesting standard risk profile
- Monosomy 7 Detection: Indicates complete loss of chromosome 7, associated with poorer prognosis
- del7q31 Deletion: Specific genetic deletion that may influence treatment decisions
- Complex Abnormalities: Multiple chromosomal changes requiring comprehensive evaluation
All results are accompanied by detailed clinical interpretation and recommendations from our specialized hematology team. Your healthcare provider will discuss the implications of your results and develop an appropriate management plan based on the genetic findings.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $150 |
| Regular Price | $188 |
Nationwide Accessibility
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our comprehensive network ensures that advanced genetic testing is accessible to patients nationwide.
Take Control of Your Health Today
Don’t wait to get the critical genetic information you need for informed medical decisions. Our specialized FISH Monosomy 7 del7q31 test provides the comprehensive analysis required for accurate diagnosis and personalized treatment planning in blood cancer management.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your test or speak with our genetic counseling team. Our experts are available to answer your questions and guide you through the testing process.
With rapid turnaround times of just 4 working days and sample collection available daily until 4 PM, we ensure timely results for your critical healthcare decisions. Trust our experienced cytogenetics team for accurate, reliable genetic testing that makes a difference in your treatment journey.
